13th ESNI COURSE | 3-6 July 2013
Program DAY ONE
Chairs: M.J. Sà and G. Martino
Learning from very experienced and inspiring neuroimmunologists – how to achieve success in clinical and laboratory research, and business in neuroimmunology
09.00 – 09.45
BIOGEN SPONSORED SYMPOSIUM
Mechanisms of tissue injury in multiple sclerosis (H. Lassmann)
09.45 – 10.30
Science and serendipity: balancing family and opportunities (A. Vincent)
10.30 – 11.00
Coffee Break
11.00 – 11.45
From discovery of a neurological autoimmune mechanism to provison of a robust diagnostic reagent (W. Stoecker)
11.45 – 12.30
Ethnicity and age may shap ethe phenotype of some neuroimmunological diseases (M.I. Leite)
12.30 – 13.30
LUNCH BREAK
Chairs: R. Karabudak and I. Elovaara
Research and clinical applications – the influence of age, ethnicity and pregnancy in neuroimmunology
13.30 – 14.15
Neuroimmunology of developmental disorders (J. Schwarz)
14.15 – 15.00
Neuroimmunology of the elderly (A. Phillips)
15.00 – 15.30
Coffee Break
15.30 – 16.15
Biomarkers (D. Karussis)
16.15 – 17.00
Neuroimmunology and pregnancy (F. Gilli)
DAY TWO
Chairs: A. Uccelli and M. Comabella
Research and clinical applications – the role of genetic factors, infections, tumours and vitamin D in neuroimmunological diseases
09.00 – 09.45
Potential genetic and environmental factors contributing to autoimmunity – relevance in neuorimmunological diseases (I. Kockum)
09.45 – 10.30
Potential role of infections in the development and course of neuroimmunological diseases – example of peripheral demyelinating diseases (H. Willison)
10.30 – 11.00
Coffee Break
11.00 – 11.45
Paraneoplastic and non-paraneoplastic encephalitis mediated by antibodies to cell-surface antigens (J. Dalmau)
11.45 – 12.30
Neurons as targets for T cells in the nervous system (R. Liblau)
12.30 – 13.30
LUNCH BREAK
Chairs: N. Grigoriadis and R. Furlan
Expansion and overlap of neuroimmunology with other specialities – neuroimmunology and the eyes, autonomic dysfunction, cognition and behaviour, and haematological and rheumatological diseases
13.00 – 14.15
Inflammatory diseases of the eye: from basic and experimental research to clinical application in neuroimmunology (R. Proenca)
14.15 – 15.00
Autonomic involvement in neuroimmunological diseases: a long journey from clinical
manifestations to the research on immunopathogenic mechanisms (J. Vershuuren)
15.00 – 15.30
Coffee Break
15.30 – 16.15
Neuroimmunological diseases with significant neuropsychiatric features: the onset of a potentially severe disease? (M.E. Coutinho)
16.15 – 17.00
Adopting and adapting haematological and rheumatological treatments: the use of monoclonal antibodies in neuroimmunological diseases of peripheral nervous system and neuromuscular junction (I. Illa)
